{"id":"NCT00049842","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)","officialTitle":"PEG-Intron(TM) Maintenance Therapy vs. an Untreated Control Group for Prevention of Progression of Fibrosis in Adult Subjects With Chronic Hepatitis C With Hepatic Fibrosis (METAVIR Fibrosis Score of F2 or F3), Who Failed Therapy With PEG-Intron Plus REBETOL(R) (in Protocol No. P02370)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-10","primaryCompletion":"2009-10","completion":"2009-10","firstPosted":"2002-11-15","resultsPosted":"2011-01-20","lastUpdate":"2017-04-04"},"enrollment":540,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C","Liver Fibrosis"],"interventions":[{"type":"BIOLOGICAL","name":"peginterferon alfa-2b (SCH 54031)","otherNames":[]}],"arms":[{"label":"PEG-Intron (peginterferon alfa-2b) 0.5 µg/kg Weekly (QW)","type":"EXPERIMENTAL"},{"label":"Untreated Control","type":"NO_INTERVENTION"}],"summary":"The objective of the study is to evaluate the safety and efficacy of PEG-Intron versus no treatment for the prevention of fibrosis progression in adult participants with moderate to severe liver fibrosis secondary to chronic hepatitis C, who failed PEG-Intron plus Rebetol treatment in protocol P02370 (NCT00039871).","primaryOutcome":{"measure":"Fibrosis Response Status (ie, Improvement, no Change, or the Worsening of the Fibrosis Score in Participants With Baseline METAVIR Fibrosis Score of F2 or F3).","timeFrame":"Baseline to up to Month-36","effectByArm":[{"arm":"PEG-Intron (Peginterferon Alfa-2b) 0.5 µg/kg Weekly (QW)","deltaMin":44,"sd":null},{"arm":"Untreated Control","deltaMin":29,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["23159770"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":53,"n":270},"commonTop":["FATIGUE","INSOMNIA","HEADACHE","ARTHRALGIA","ASTHENIA"]}}